Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
The Prostate|December 14, 2002
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesionsGlen Kristiansen, Christian Pilarsky, Christoph Wissmann, et al.
The Prostate|January 15, 2009
Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acidMichael Lein, Kurt Miller, Manfred Wirth, et al.
World Journal of Urology|January 17, 2026
Barriers to post-prostatectomy stress incontinence care: knowledge gaps, patient concerns, and urologist communicationViktoria Menzel, Christer Groeben, Falk Hoffmann, et al.
World Journal of Urology|September 19, 2019
Long-term functional outcomes after robotic vs. retropubic radical prostatectomy in routine care: a 6-year follow-up of a large German health services research studyMartin Baunacke, Maria-Luisa Schmidt, Christian Thomas, et al.
European Urology|March 24, 2004
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancerManfred P Wirth, Lothar Weissbach, Franz-Josef Marx, et al.
The Journal of Urology|October 26, 2020
Surgical Reintervention Rates after Invasive Treatment for Lower Urinary Tract Symptoms due to Benign Prostatic Syndrome: A Comparative Study of More than 43,000 Patients with Long-Term FollowupChristian Gilfrich, Matthias May, Claus Fahlenbrach, et al.
The Journal of Urology|September 14, 2019
Decision Regret after Radical Prostatectomy does Not Depend on Surgical Approach: 6-Year Followup of a Large German Cohort Undergoing Routine CareMartin Baunacke, Maria-Luisa Schmidt, Christer Groeben, et al.
World Journal of Urology|December 2, 2020
Treatment of post-prostatectomy urinary incontinence and erectile dysfunction: there is insufficient utilisation of care in German cancer survivorsMartin Baunacke, Maria-Luisa Schmidt, Christer Groeben, et al.
European Urology|February 27, 2007
Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progressionMichael Lein, Manfred Wirth, Kurt Miller, et al.
World Journal of Urology|May 14, 2014
A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral centerAndreas Becker, Daniel Seiler, Maciej Kwiatkowski, et al.
Pageof 5